Valuation : Yuhan Corporation

Market Cap 5,886B 4.37B 3.76B 3.55B 3.23B 6.04B 418B 6.1B 42.27B 16.27B 212B 16.43B 16.07B 674B P/E 2026 *
39.5x
P/E 2027 * 29.7x
Enterprise Value 5.81B 4.31M 3.71M 3.5M 3.19M 5.96M 413M 6.02M 41.7M 16.05M 209M 16.2M 15.85M 665M EV / Sales 2026 *
2.48x
EV / Sales 2027 * 2.27x
Free-Float
61.43%
Yield 2026 *
0.72%
Yield 2027 * 0.72%
1 day-1.38%
1 week-3.07%
Current month-5.73%
1 month-3.78%
3 months+2.60%
6 months-19.90%
Current year-29.80%
1 week 78,000
Extreme 78000
82,000
1 month 77,500
Extreme 77500
87,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 19/03/2021
Director of Finance/CFO 58 -
President 67 15/03/2024
Director TitleAgeSince
Chairman 74 19/03/2021
Director/Board Member 71 20/03/2015
Director/Board Member 62 01/03/2020
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 A Buy

Chairperson

200 0.0002%
6/25/25 A Buy

Chief Executive Officer

720 0.0009%
6/24/25 A Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.38%-3.07%-33.97%+13.49% 4.37B
-1.91%-5.01%+72.21%+32.70% 357B
-0.02%-3.17%+21.92%-20.27% 66.56B
-0.36%-3.39%+41.16%+177.85% 12.14B
-0.66%-8.82%-11.70%-16.24% 7.5B
-0.48%-3.47%-23.84%+1.83% 4.85B
-2.27%-6.14%-35.86%-9.87% 2.89B
-0.90%-5.19%-9.78%+36.29% 2.42B
-1.17%-3.71%-25.81%-20.42% 1.94B
-0.35%-0.24%-24.33%-12.24% 1.69B
Average -0.95%-3.99%-3.00%+18.31% 46.14B
Weighted average by Cap. -1.54%-3.10%+58.89%+26.94%

Financials

2026 *2027 *
Net sales 2,337B 1.74B 1.49B 1.41B 1.28B 2.4B 166B 2.42B 16.78B 6.46B 84.21B 6.52B 6.38B 267B 2,540B 1.89B 1.62B 1.53B 1.4B 2.61B 180B 2.63B 18.24B 7.02B 91.53B 7.09B 6.93B 291B
Net income 154B 114M 98.14M 92.59M 84.35M 158M 10.91B 159M 1.1B 424M 5.53B 429M 419M 17.58B 198B 147M 126M 119M 109M 203M 14.05B 205M 1.42B 547M 7.13B 552M 540M 22.64B
Net Debt -80.13B -59.55M -51.21M -48.32M -44.02M -82.28M -5.69B -83.03M -575M -221M -2.89B -224M -219M -9.17B -112B -82.86M -71.26M -67.24M -61.25M -115M -7.92B -116M -801M -308M -4.02B -311M -304M -12.76B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
10/09/26 ₩78,900.00 -1.38% 409,069
09/09/26 ₩80,000.00 +1.14% 141,783
08/09/26 ₩79,100.00 -1.98% 163,702
07/09/26 ₩80,700.00 -0.86% 178,343
04/09/26 ₩81,400.00 0.00% 108,985
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
78,900.00KRW
Average target price
117,176.47KRW
Spread / Average Target
+48.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!